Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia / Lone Baandrup en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 2 (Febrero)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 2 (Febrero) . - pp. 103-108 Título : Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia : a population based nested case-control study Tipo de documento: texto impreso Autores: Lone Baandrup, Autor ; Christiane Gasse, Autor ; Vibeke D. Jensen, Autor Fecha de publicación: 2022 Artículo en la página: pp. 103-108 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiacepinas, Causa de muerte, Farmacoterapia, Esquizofrenia. Resumen: Concomitant prescription of more than 1 antipsychotic agent (antipsychotic polypharmacy) in the treatment of schizophrenia is prevalent, although monotherapy is generally recommended. Mortality from natural causes is markedly increased in schizophrenia, and the role of polypharmacy remains controversial. Link: ./index.php?lvl=notice_display&id=28129 [artículo] Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia : a population based nested case-control study [texto impreso] / Lone Baandrup, Autor ; Christiane Gasse, Autor ; Vibeke D. Jensen, Autor . - 2022 . - pp. 103-108. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 2 (Febrero) . - pp. 103-108 Palabras clave: Antipsicóticos, Benzodiacepinas, Causa de muerte, Farmacoterapia, Esquizofrenia. Resumen: Concomitant prescription of more than 1 antipsychotic agent (antipsychotic polypharmacy) in the treatment of schizophrenia is prevalent, although monotherapy is generally recommended. Mortality from natural causes is markedly increased in schizophrenia, and the role of polypharmacy remains controversial. Link: ./index.php?lvl=notice_display&id=28129

---

1 (1 - 1 / 1)